detected in vitro. Further characterization of IN1-NM showed that it produced a cytoplasmic 62K flagellin subunit protein, but this protein lacked six epitopes detected in IN1 and also differed in its two-dimensional gel electrophoresis pattern. The results of these studies support the concept that an intact flagellum is necessary for intestinal infection with C. jejuni and that this model may be useful for studying the immune response to C.
jejuni.
Studies during the past few years have shown that the flagella of Campylobacterjejuni, a common cause of human gastrointestinal infection, may be important pathogenic determinants in helping the organism establish infection in the gastrointestinal tract. In vitro studies suggest a role for flagella in pathogenesis by means of motility (15) or attachment (14, 21) , but the mechanism is not known. Few studies have been performed in animals (1, 4, 20, 21, 28) or humans (2) addressing the role of campylobacter flagella in causing infection. A few previous studies have used aflagellate variants in vivo; however, these variants have had relatively high frequencies of reversion (4) to the motile phenotype.
In 1985, Humphrey et al. (9, 10) reported on a hamster model of C. jejuni infection. We developed this model in our laboratory to study the biologic function of campylobacter flagella in vivo. Contrary to the reports by Humphrey and colleagues, with identical protocols we were unable to induce diarrhea or colitis in hamsters. During the course of these experiments, however, we found significant differences in the ability of the flagellate and nonflagellate variants of C. jejuni to establish asymptomatic infection. Importantly, we used a Fla-variant with high in vitro stability to assess the importance of campylobacter flagella in infection. Additionally, infected hamsters mounted a systemic immune response to local infection with C. jejuni and, in preliminary experiments, were protected from homologous challenge.
MATERIALS AND METHODS
Strains. C. jejuni IN1 (Fla' Mot') (16) (9, 10) . C. jejuni was grown in brucella broth (BBL) containing 10% horse erythrocyte extract and antimicrobial agents. After 24 h of growth in this medium, organisms grew to approximately 109 to 1010 CFU/ml. Before inoculation, a sample of culture was diluted and plated to determine inoculum size. Broth cultures were kept at 37°C under microaerophilic conditions during transport of cultures to the animal holding facility and kept at this temperature until immediately before use. Animals were anesthetized with ketamine and xylazine (both from H. Schien, Inc., Port Washington, N.Y.) intraperitoneally. After anesthesia was induced, a blood sample was obtained from each hamster either by phlebotomy of the retroorbital sinus or cardiac puncture. A small lower medial laparotomy was performed, and 5 ml of broth culture was injected into the exposed cecum with a 23-gauge needle. Closure of the incision was performed with metallic surgical clips. On days 1, 2, 3, 7, 10, and 14 and weekly thereafter, stool specimens were collected and weighed, and dilutions of suspensions in saline were plated to quantitate excretion of C. jejuni and to determine the frequency of the appearance of motility variants. Several colonies from each set of dilution plates were stained with flagellar stain for confirmation. Animals were observed during this period for indications of illness, i.e., wet tail, diarrhea, or fatigue.
ELISA. Pre-and postchallenge serum specimens were tested by an enzyme-linked immunosorbent assay (ELISA) with purified flagellin from IN1 and outer membrane proteins from IN1-NM as antigens. Flagellin from IN1 was purified as previously described (16) . Outer membrane proteins were prepared by Sarkosyl (CIBA-GEIGY Corp., Summit, N.J.) extraction as described by Logan and Trust (12) . Antigens were used at a concentration of 10 ,ug/ml, and ELISA plates were coated with 150 ,ul per well. Alkaline phosphataseconjugated goat anti-hamster immunoglobulin G (IgG) (Accurate Chemical and Scientific Corp., Wesbury, N.Y.) was used as a secondary antibody, and p-nitrophenyl phosphate (Sigma Chemical Co., St. Louis, Mo.) was used as the substrate. The ELISA was performed as described by Voller and Bidwell (29) , except that the blocking and dilution buffer was phosphate-buffered saline-1% bovine serum albumin.
Electrophoretic methods. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed by the method of Laemmli (11), and all gels were stained with silver stain (24) . Two-dimensional gel electrophoresis of proteins was performed by the method of O'Farrell (25) with a Protein II Slab Cell (Bio-Rad Laboratories, Richmond, Calif.) as described by the manufacturer. Western immunoblots were performed as previously described (17) .
Monoclonal antibodies. Monoclonal antibodies directed against campylobacter flagellin were produced as previously described (18) . Monoclonal antibody (MAb) 10-44 has been previously described (18) . Additional antibodies were further characterized by Western blotting with purified flagellin and/or cyanogen bromide fragments as the antigen. Antibodies with different flagellin specificities were selected based on their binding patterns with CNBr fragments and flagellins with a panel of 10 C. jejuni strains of different serotypes (16) .
Restriction enzyme analysis. Total cellular DNA preparations from C. jejuni were isolated by the method of Tompkins et al. (27) . DNA was digested with HindIll, Sau3A, PstI, BamHI, and EcoRV (all from Bethesda Research Laboratories, Inc., Gaithersburg, Md.) as specified by the manufacturer.
Statistical analysis. Analysis was performed as described by Siegel (26) .
RESULTS
During initial hamster challenge studies, a nonmotile variant of IN1 was observed on dilution plates of IN1 that was phenotypically distinct from the wild type. Examination of this variant by light microscopy with a flagellar stain and negative-stain electron microscopy showed that the variant was aflagellate. This variant was nonmotile as tested in motility agar.
Hamster infection. To assess the role of an intact flagellum in the pathogenesis of C. jejuni infections, we performed intracecal inoculation of hamsters with IN1 and the aflagellate variant IN1-NM. Neither strain caused symptomatic disease, and only minor histopathologic changes were seen in sections of the intestinal tract. The results of these studies are summarized in Table 1 whether the expression of an intact flagellum in IN1 was reversible, bacteria were plated out and examined for colonial variants consistent with altered motility, and colonies were confirmed as aflagellate by flagellar stain. We found that the change from the Fla' to Fla-phenotype could be detected in vitro and had a frequency of 9.2 x 106 per cell per generation. However, we could not detect any in vitro reversion from Fla-to Fla' when examining up to 150,000 colonies. We also used the agar pour plate method of Caldwell et al. (4) to examine reversibility in these strains and could not demonstrate Fla--to-Fla+ reversion in vitro. Fla+-to-Fla-reversion could not be demonstrated because of the high motility of IN1. Increasing the agar concentration in the pour plates was not effective in reducing motility to the extent needed to detect nonmotile variants as well.
When whole-cell lysates of both strains were examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis ( Fig. 1 ), no differences in protein profiles were observed except for marked reduction in the 62K flagellin protein.
Growth of IN1-NM for increasing amounts of time (lanes 3 through 6) did not affect the lack of expression of flagellin. We then used acid dissociation-reassociation methods for purifying intact flagella to determine whether both C. jejuni variants were capable of making intact flagella (Fig. 2) . A 62K flagellin subunit was purified from IN1 by using these methods; however, flagellin was absent in the preparation all eight antibodies used (data not shown). This suggests that the flagellin in these variants undergoes antigenic variation associated with the ability to assemble an intact flagellum.
In a previous study, we showed that flagellins from C. jejuni have a unique two-dimensional gel electrophoresis pattern, producing multiple charged protein species of identical molecular weight (19) . To determine whether the flagellin from IN1-NM was different from that of the motile strain IN1, we performed two-dimensional electrophoretic analysis of whole-cell lysates from both strains (Fig. 5) and Western blot analysis with MAb Fil. IN1 shows multiple charged species reacting with MAb Fli (Fig. 5A) , consistent with our previous findings. However, IN1-NM exhibited only one major charged species when reacted with MAb Fil (Fig.   5B ).
Challenge study. To assess whether local immunity was established after infection, we performed a preliminary rechallenge study. Animals challenged with IN1 (group 1) and uninoculated controls (group 2) were monitored until the organisms were cleared from the gastrointestinal tract. We then challenged the animals with IN1 and found that none of the four group 1 animals became reinfected, whereas four of the five animals in group 2 did. We then challenged group 1 animals again with a heterologous C. jejuni isolate, IN8; three of four animals became infected with IN8. These preliminary experiments suggest that infection with C. jejuni in hamsters elicits local protective immunity that is type specific.
DISCUSSION
Initial studies by Humphrey and colleagues (9, 10) suggested that the hamster might be an extremely valuable small animal model for campylobacter infection, since colitis and diarrhea occurred regularly after inoculation. Attempts in our laboratory to reproduce symptomatic disease reported by these authors have been unsuccessful. IN1 is a clinical isolate obtained from a patient with bloody diarrhea. Perhaps the reason for this lack of symptoms is due to the strain used in this study. Unfortunately, the original isolates used by Humphrey and colleagues are not available (C. D. Humphrey and F. Pittman, personal communication). We have performed additional experiments with other C. jejuni isolates. Two isolates from patients with colitis provided by Martin Blaser (3) were found not to induce diarrhea in our model. Another clinical isolate, IN8, has also been tried, without success. Alternatively, the strain of hamsters used in this study might be refractory to symptomatic infection. An early study by Field et al. (5) found that hamsters were resistant to colonization; however, a lower inoculum (6.5 x 108 CFU) was used. Additional studies are needed with hamsters from different sources to assess this possibility.
Despite the lack of symptomatic disease, we were able to use a stable Fla-variant of IN1 to study the role of flagella in the establishment of infection. Our studies clearly show that Fla' C. jejuni are able to infect hamsters more readily than the Fla-variant. One hamster of 42 in our studies excreted the Fla-variant for up to 7 days postchallenge. The mechanism by which this animal became infected with a nonmotile organism is not understood and will need further study.
Recovery of Fla' revertants from hamsters inoculated with a Fla-strain shows that the Fla' strains may have some selective advantage over Fla-strains in vivo. Since this apparent reversion was observed when 109 to 1010 organisms were inoculated, this suggests a very low frequency of reversion in the Fla--to-Fla+ direction with the variants used in this study. The reversion from Fla' to Flain IN1 was several orders of magnitude less than that reported for variants of C. jejuni 81116 and A3249 reported by Caldwell et al. (4) . Although the mechanism for reversible expression of flagella in INI is not know, the results of Western blot experiments with a panel of different monoclonal antibodies showed that the reversibility from Fla-to Fla' in IN1 was associated with antigenic variation of the flagellin protein.
Few in vivo studies have addressed the role of flagella in causing infection. Black et al. (2) 
